Abstract:Aims and objectives: Astragaloside IV (AS-IV) has been found to possess anti-oxidative, anti-inflammatory, and anti-apoptotic properties, but its effect on atrial fibrosis is yet to be determined. This research investigates the protective role of AS-IV in angiotensin II (Ang II)-induced atrial fibrosis and atrial fibrillation (AF). Methods: C57BL/6 male mice aged 8-10 weeks (n = 40) were subcutaneously administered Ang II (2.0 mg/kg/day) or saline, with AS-IV (80 mg/kg) intraperitoneally administered 2 h before Ang II infusion for 4 weeks. Biochemical, histological, and morphological analyses were carried out. Using transesophageal burst pacing, AF was generated in vivo. Results: Here, we report that AS-IV treatment inhibited Ang II-induced AF development in mice (58 ± 5.86 vs 15.13 ± 2.16 %, p < 0.001). Ang II + AS-IV therapy was effective in reducing the atrial fibrotic area and decreasing the increase in smooth muscle alpha-actin (α-SMA)-positive myofibroblasts brought on by Ang II treatment (fibrotic area: 26.25 ± 3.81 vs 8.62 ± 1.83 %, p < 0.001 and α-SMA: 65.62 ± 10.63 vs 17.25 ± 1.78 %, p < 0.001). The reactive oxygen species (ROS) production was reduced by pretreatment with Ang II + AS-IV (9.20 ± 0.92 vs 2.63 ± 0.22 %/sec, p < 0.001). In addition, Ang II + AS-IV treatment suppressed oxidative stress in Ang II-induced atrial fibrosis (malondialdehyde: 701.78 ± 85.01 vs 504.07 ± 25.62 pmol/mg protein, p < 0.001; superoxide dismutase: 13.82 ± 1.25 vs 29.54 ± 2.45 U/mg protein, p < 0.001 and catalase: 11.43 ± 1.19 vs 20.83 ± 3.29 U/mg protein, p < 0.001, respectively). Moreover, Ang II + AS-IV decreased the expression of α-SMA, collagen III and collagen I (3.32 ± 0.53 vs 1.41 ± 0.20 fold, p < 0.001; 3.41 ± 0.55 vs 1.48 ± 0.18 fold, p < 0.001; 2.34 ± 0.55 vs 0.99 ± 0.17 fold, p < 0.001, respectively) while increasing the protein expression of sirtuin 1 (SIRT1), peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α), and fibronectin type III domain-containing protein 5 (FNDC5) in Ang II-treated mice (0.22 ± 0.02 vs 0.57 ± 0.08 fold, p < 0.001; 0.28 ± 0.04 vs 0.72 ± 0.05 fold, p < 0.001; 0.38 ± 0.03 vs 0.68 ± 0.06 fold, p < 0.001, respectively). Conclusion: Our data led us to speculate that AS-IV may protect against Ang II-induced atrial fibrosis and AF via upregulation of the SIRT1/PGC-1α/FNDC5 pathway.

Aristoyunnolin H Attenuates Extracellular Matrix Secretion in Cardiac Fibroblasts by Inhibiting Calcium Influx

Alendronate prevents angiotensin II-induced collagen I production through geranylgeranylation-dependent RhoA/Rho kinase activation in cardiac fibroblasts.

Inhibition of Farnesylpyrophosphate Synthase Prevents Angiotensin II-induced Hypertrophic Responses in Rat Neonatal Cardiomyocytes: Involvement of the RhoA/Rho Kinase Pathway

[Effects of Angiotensin Converting Enzyme Inhibitor on the Expression of Angiotensin Converting Enzyme 2 in Atrium of Patients with Atrial Fibrillation].

17Β-Estradiol Inhibits Angiotensin II-induced Collagen Synthesis of Cultured Rat Cardiac Fibroblasts Via Modulating Angiotensin II Receptors

Inhibitory Effect of Ethyl Acetate Extract of Aristolochia Yunnanensis on Cardiac Fibrosis Through Extracellular Signal-Regulated Kinases 1/2 and Transforming Growth Factor Β/small Mother Against Decapentaplegic Signaling Pathways

Puerarin Decreases Collagen Secretion in AngII-Induced Atrial Fibroblasts Through Inhibiting Autophagy Via the JNK-Akt-mTOR Signaling Pathway.

Cryptotanshinone attenuates cardiac fibrosis via downregulation of COX-2, NOX-2, and NOX-4

[The Influence of Angiotensin II Receptor Blockade on the Expressions of Col I and TIMP-1 Mrna in Cardiac Fibroblast of Adult Rat].

Inhibitory effect of resveratrol on cardiac fibroblast proliferation induced by angiotensin II]

The Signalling of At2 and the Influence on the Collagen Metabolism of At2 Receptor in Adult Rat Cardiac Fibroblasts

Tadalafil Attenuates Angiotensin II-Induced Extracellular Matrix Remodeling in Cardiac Fibroblasts Through TGF-β1/Smad3 Signaling Pathway

Angiotensin II-stimulated Collagen Synthesis in Aortic Adventitial Fibroblasts is Mediated by Connective Tissue Growth Factor.

All-trans Retinoic Acid Inhibited Angiotensin II-induced Increase in Cell Growth and Collagen Secretion of Neonatal Cardiac Fibroblasts.

Salvianolic Acid B-Alleviated Angiotensin II Induces Cardiac Fibrosis by Suppressing NF-κB Pathway In Vitro

Effects of Angiotensin II Receptor Blockade on Hepatic Fibrosis in Rats.

Dihydro-artemisinin inhibits angiotensin II-induced cardiac fibroblasts proliferation and induces apoptosis through phosphoinositide 3-kinase/akt pathway

Effects of Angiotensin(1-7) on Cell Proliferation and Collagen Synthesis of Cardiac Fibroblasts Induced by Angiotensin II

Salvianolic Acid A Attenuates Angiotensin Ii-Induced Cardiac Fibrosis Through Regulating The Txnip Signaling Pathway

A novel caffeic acid derivative prevents angiotensin II-induced cardiac remodeling

Astragaloside IV inhibits angiotensin II-induced atrial fibrosis and atrial fibrillation by SIRT1/PGC-1α/FNDC5 pathway